Proactive monitoring and dose adjustment of infliximab, a medication commonly used to treat inflammatory bowel disease (IBD), could improve a patient’s chances of having a long-term successful response to therapy, a pilot observational study at...
11-Sep-2014 11:00 AM EDT
Research led by investigators at Beth Israel Deaconess Medical Center helps explain the heat-generating properties of brown fat, a possible to key to weight loss.
30-Jun-2014 9:20 AM EDT
The Institute for RNA Medicine, launched by the BIDMC Cancer Center, brings together leading investigators to pursue new lines of inquiry into non-coding RNA,.
30-Jun-2014 3:00 PM EDT
Using a zebrafish model, investigators have identified a drug compound that appears to reverse arrhythmogenic cardiomyopathy, a hereditary disease and leading cause of sudden death in young people.
11-Jun-2014 10:00 AM EDT
New findings from Beth Israel Deaconess Medical Center add a surprising new dimension to the understanding of antibody repertoires and their potential to better fight disease.
9-Jun-2014 3:00 PM EDT
Important revelations regarding endothelial cell behavior are emerging from vascular simulation research, as highlighted in two recent papers from investigators at Beth Israel Deaconess Medical Center.
8-May-2014 11:00 AM EDT
By linking cancer gene expression patterns with drug activity, a research team from Beth Israel Deaconess Medical Center finds a possible cancer therapy hidden in an antimicrobial agent.
5-May-2014 8:00 AM EDT
Martin R. Pollak, MD, Chief of Nephrology at Beth Israel Deaconess Medical Center has been elected to the National Academy of Sciences.
30-Apr-2014 3:45 PM EDT